- Home
- CIFR vs PAHC Comparison
CIFR vs PAHC Comparison
Compare CIFR & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIFR
- PAHC
- Stock Information
- Founded
- CIFR 2021
- PAHC 1946
- Country
- CIFR United States
- PAHC United States
- Employees
- CIFR N/A
- PAHC N/A
- Industry
- CIFR Investment Bankers/Brokers/Service
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- CIFR Finance
- PAHC Health Care
- Exchange
- CIFR Nasdaq
- PAHC Nasdaq
- Market Cap
- CIFR 1.2B
- PAHC 968.3M
- IPO Year
- CIFR N/A
- PAHC 2014
- Fundamental
- Price
- CIFR $4.78
- PAHC $25.61
- Analyst Decision
- CIFR Strong Buy
- PAHC Sell
- Analyst Count
- CIFR 10
- PAHC 4
- Target Price
- CIFR $7.58
- PAHC $21.25
- AVG Volume (30 Days)
- CIFR 31.8M
- PAHC 235.7K
- Earning Date
- CIFR 08-12-2025
- PAHC 05-07-2025
- Dividend Yield
- CIFR N/A
- PAHC 1.89%
- EPS Growth
- CIFR N/A
- PAHC 140.17
- EPS
- CIFR N/A
- PAHC 0.78
- Revenue
- CIFR $152,092,000.00
- PAHC $1,190,682,000.00
- Revenue This Year
- CIFR $88.07
- PAHC $28.33
- Revenue Next Year
- CIFR $68.21
- PAHC $13.78
- P/E Ratio
- CIFR N/A
- PAHC $32.60
- Revenue Growth
- CIFR N/A
- PAHC 19.12
- 52 Week Low
- CIFR $1.86
- PAHC $16.16
- 52 Week High
- CIFR $7.99
- PAHC $26.55
- Technical
- Relative Strength Index (RSI)
- CIFR 69.24
- PAHC 67.45
- Support Level
- CIFR $3.65
- PAHC $24.59
- Resistance Level
- CIFR $4.03
- PAHC $25.37
- Average True Range (ATR)
- CIFR 0.32
- PAHC 0.74
- MACD
- CIFR 0.06
- PAHC -0.01
- Stochastic Oscillator
- CIFR 94.90
- PAHC 97.23
About CIFR Cipher Mining Inc.
Cipher Mining Inc ia an emerging technology company that operates in the Bitcoin mining ecosystem in the United States. The company is developing a cryptocurrency mining business, specializing in Bitcoin. The company is expanding and strengthening the Bitcoin network's critical infrastructure in the United States.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.